vs
Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $151.7M, roughly 1.5× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 4.4%, a 3.4% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $22.7M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 5.1%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
CSW vs NUTX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $233.0M | $151.7M |
| Net Profit | $10.3M | $11.8M |
| Gross Margin | 39.7% | 30.4% |
| Operating Margin | 7.4% | 20.4% |
| Net Margin | 4.4% | 7.8% |
| Revenue YoY | 20.3% | -41.1% |
| Net Profit YoY | -61.9% | -80.8% |
| EPS (diluted) | $0.62 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $233.0M | $151.7M | ||
| Q3 25 | $277.0M | $267.8M | ||
| Q2 25 | $263.6M | $244.0M | ||
| Q1 25 | $230.5M | $211.8M | ||
| Q4 24 | $193.6M | $257.6M | ||
| Q3 24 | $227.9M | $78.8M | ||
| Q2 24 | $226.2M | $76.1M | ||
| Q1 24 | $210.9M | $67.5M |
| Q4 25 | $10.3M | $11.8M | ||
| Q3 25 | $40.7M | $55.4M | ||
| Q2 25 | $40.9M | $-17.7M | ||
| Q1 25 | $35.1M | $21.2M | ||
| Q4 24 | $26.9M | $61.6M | ||
| Q3 24 | $36.1M | $-8.8M | ||
| Q2 24 | $38.6M | $-364.0K | ||
| Q1 24 | $31.8M | $-364.0K |
| Q4 25 | 39.7% | 30.4% | ||
| Q3 25 | 43.0% | 57.8% | ||
| Q2 25 | 43.8% | 51.2% | ||
| Q1 25 | 44.2% | 55.9% | ||
| Q4 24 | 41.4% | 55.0% | ||
| Q3 24 | 45.6% | 27.8% | ||
| Q2 24 | 47.5% | 29.7% | ||
| Q1 24 | 44.4% | 15.1% |
| Q4 25 | 7.4% | 20.4% | ||
| Q3 25 | 20.5% | 48.7% | ||
| Q2 25 | 20.8% | 13.8% | ||
| Q1 25 | 19.5% | 38.1% | ||
| Q4 24 | 15.3% | 44.4% | ||
| Q3 24 | 22.6% | 12.3% | ||
| Q2 24 | 24.3% | 7.0% | ||
| Q1 24 | 21.0% | 2.1% |
| Q4 25 | 4.4% | 7.8% | ||
| Q3 25 | 14.7% | 20.7% | ||
| Q2 25 | 15.5% | -7.3% | ||
| Q1 25 | 15.2% | 10.0% | ||
| Q4 24 | 13.9% | 23.9% | ||
| Q3 24 | 15.8% | -11.2% | ||
| Q2 24 | 17.1% | -0.5% | ||
| Q1 24 | 15.1% | -0.5% |
| Q4 25 | $0.62 | $2.34 | ||
| Q3 25 | $2.41 | $7.76 | ||
| Q2 25 | $2.43 | $-2.95 | ||
| Q1 25 | $2.05 | $3.33 | ||
| Q4 24 | $1.60 | $11.56 | ||
| Q3 24 | $2.26 | $-1.72 | ||
| Q2 24 | $2.47 | $-0.07 | ||
| Q1 24 | $2.03 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.2M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $329.4M |
| Total Assets | $2.3B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.2M | $185.6M | ||
| Q3 25 | $31.5M | $166.0M | ||
| Q2 25 | $38.0M | $96.7M | ||
| Q1 25 | $225.8M | $84.7M | ||
| Q4 24 | $213.8M | $40.6M | ||
| Q3 24 | $273.2M | $46.9M | ||
| Q2 24 | $18.9M | $40.8M | ||
| Q1 24 | $22.2M | $30.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
| Q4 25 | $1.1B | $329.4M | ||
| Q3 25 | $1.1B | $317.2M | ||
| Q2 25 | $1.1B | $235.3M | ||
| Q1 25 | $1.1B | $176.9M | ||
| Q4 24 | $1.0B | $132.4M | ||
| Q3 24 | $1.0B | $60.4M | ||
| Q2 24 | $650.2M | $62.7M | ||
| Q1 24 | $615.7M | $63.0M |
| Q4 25 | $2.3B | $918.5M | ||
| Q3 25 | $1.5B | $964.5M | ||
| Q2 25 | $1.5B | $841.0M | ||
| Q1 25 | $1.4B | $761.9M | ||
| Q4 24 | $1.4B | $655.3M | ||
| Q3 24 | $1.4B | $438.5M | ||
| Q2 24 | $1.1B | $422.4M | ||
| Q1 24 | $1.0B | $404.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $70.4M |
| Free Cash FlowOCF − Capex | $22.7M | $69.0M |
| FCF MarginFCF / Revenue | 9.8% | 45.5% |
| Capex IntensityCapex / Revenue | 2.6% | 0.9% |
| Cash ConversionOCF / Net Profit | 2.81× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $162.0M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.9M | $70.4M | ||
| Q3 25 | $61.8M | $99.5M | ||
| Q2 25 | $60.6M | $27.3M | ||
| Q1 25 | $27.3M | $51.0M | ||
| Q4 24 | $11.6M | $54.0K | ||
| Q3 24 | $66.8M | $6.8M | ||
| Q2 24 | $62.7M | $13.3M | ||
| Q1 24 | $22.4M | $3.1M |
| Q4 25 | $22.7M | $69.0M | ||
| Q3 25 | $58.7M | $99.2M | ||
| Q2 25 | $57.7M | $26.5M | ||
| Q1 25 | $22.8M | $50.9M | ||
| Q4 24 | $8.5M | $-341.0K | ||
| Q3 24 | $61.3M | $6.2M | ||
| Q2 24 | $59.6M | $12.7M | ||
| Q1 24 | $17.5M | $2.3M |
| Q4 25 | 9.8% | 45.5% | ||
| Q3 25 | 21.2% | 37.0% | ||
| Q2 25 | 21.9% | 10.9% | ||
| Q1 25 | 9.9% | 24.0% | ||
| Q4 24 | 4.4% | -0.1% | ||
| Q3 24 | 26.9% | 7.8% | ||
| Q2 24 | 26.3% | 16.7% | ||
| Q1 24 | 8.3% | 3.4% |
| Q4 25 | 2.6% | 0.9% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | 1.1% | 0.3% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.4% | 0.8% | ||
| Q2 24 | 1.4% | 0.7% | ||
| Q1 24 | 2.3% | 1.1% |
| Q4 25 | 2.81× | 5.95× | ||
| Q3 25 | 1.52× | 1.80× | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 0.78× | 2.40× | ||
| Q4 24 | 0.43× | 0.00× | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
